ASEP Medical Holdings Inc. (CSE:ASEP)
Canada · Delayed Price · Currency is CAD 0.2500
+0.0100 (4.17%)
Aug 24, 2026, 9:04 AM EST
ASEP Medical Holdings Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -4.56 | -4.92 | -8.27 | -8.23 | -4.52 | -2.4 |
Depreciation & Amortization | 0.64 | 0.71 | 1.29 | 1.28 | 1.27 | 0.19 |
Other Amortization | - | - | 0.01 | 0.02 | 0.02 | 0.09 |
Asset Writedown & Restructuring Costs | 4.39 | 4.39 | 9.88 | - | - | - |
Loss (Gain) From Sale of Investments | 0.01 | 0.04 | -0.27 | - | - | - |
Loss (Gain) on Equity Investments | - | - | 0.18 | - | - | - |
Stock-Based Compensation | - | 0 | 0.6 | 2.09 | 0.97 | 1.04 |
Other Operating Activities | -2.29 | -2.3 | -5.73 | 0.48 | -0.92 | 0.13 |
Change in Accounts Payable | 0.9 | 1.17 | 1.82 | 0.57 | 0.38 | 0.16 |
Change in Other Net Operating Assets | -0.1 | -0.11 | 0.15 | 1.08 | -0.8 | -0.51 |
Operating Cash Flow | -1.02 | -1.02 | -0.34 | -2.71 | -3.61 | -1.3 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | - | -0 | - | -0.07 |
Cash Acquisitions | - | - | - | - | 0.13 | 0.29 |
Sale (Purchase) of Intangibles | - | - | -0 | -0 | -0 | -0.05 |
Investment in Securities | 0.95 | 0.95 | - | - | - | - |
Investing Cash Flow | 0.75 | 0.75 | -0 | -0 | 0.12 | 0.16 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 0.4 | 0.29 | 0.02 | 0.33 | - |
Total Debt Issued | 0.38 | 0.4 | 0.29 | 0.02 | 0.33 | 0.55 |
Net Debt Issued (Repaid) | 0.38 | 0.4 | 0.29 | 0.02 | 0.33 | 0.55 |
Issuance of Common Stock | - | - | - | 0.06 | - | 0.15 |
Other Financing Activities | - | - | - | 0.57 | - | 6.21 |
Financing Cash Flow | 0.38 | 0.4 | 0.29 | 0.65 | 0.33 | 6.91 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 0.11 | 0.13 | -0.05 | -2.07 | -3.16 | 5.77 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.02 | -1.02 | -0.34 | -2.71 | -3.61 | -1.37 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -302.13% | -302.24% | -113.29% | -12837.39% | - | - |
Free Cash Flow Per Share | -0.09 | -0.10 | -0.04 | -0.44 | -0.64 | -0.64 |
Levered Free Cash Flow | -1.15 | -1.41 | 1.44 | -0.22 | -0.13 | 0.31 |
Unlevered Free Cash Flow | -1.13 | -1.39 | 1.44 | -0.22 | -0.13 | 0.29 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | 0.8 | 1.06 | 1.97 | 1.65 | -0.42 | -0.35 |